473732-82-0

Basic information

• Product Name: 2,2-dimethyl-1-thien-2-ylpropan-1-amine
• Synonyms: 2,2-dimethyl-1-thien-2-ylpropan-1-amine
• CAS NO: 473732-82-0
• Molecular Formula: C₉H₁₅NS
• Molecular Weight: 169.2871
• Mol File: 473732-82-0.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,2-dimethyl-1-thien-2-ylpropan-1-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-dimethyl-1-thien-2-ylpropan-1-amine(473732-82-0)
• EPA Substance Registry System: 2,2-dimethyl-1-thien-2-ylpropan-1-amine(473732-82-0)

Safety Data

• Hazardous Substances Data: 473732-82-0(Hazardous Substances Data)

Usage

Type of compound

Synthetic compound

Properties

Antidepressant and anxiolytic (reduces anxiety)

Function

Modulates levels of serotonin and norepinephrine in the brain

Classification

Tricyclic antidepressant (non-traditional)

Uses

Treatment of depression, anxiety, and other mood disorders

Additional potential uses

Treatment of chronic pain and post-traumatic stress disorder (PTSD)

Safety

Should be used under the guidance of a healthcare professional due to potential adverse effects and interactions with other medications.

Relevant articles and documents

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.